Clinical Trial Update: Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a personalized preparative regimen prior to T-depleted allogeneic HSCT in children with chemoresistant acute leukemias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: Refractory Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia | Phase 3 | Status: UNKNOWN